More on MAXY

- Summary
- Chart
- Profile
- Historical


- Earnings
- Holders
- Dividends


Income Statement
Balance Sheet
Cash Flow Statement


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

MAXY Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 74.38M
Receivable from Perseid
Available-for-sale investment in equity securities 22K
Prepaid expenses and other current assets 199K
Assets of discontinued operations
Total current assets 79.6M
Property and equipment, net 87K
Other noncurrent assets
Total assets 79.69M
Accounts payable 381K
Accrued compensation 2.14M
Distribution payable 607K
Other accrued liabilities 297K
Liabilities of discontinued operations
Total current liabilities 3.43M
Non-current distribution payable
Other non-current liabilities 52K
Commitments and contingencies (Notes 4 and 5) 0
Stockholders' equity:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding at December 31, 2010 and June 30, 2011 0
Common stock, $0.0001 par value, 100,000,000 shares authorized, 29,210,411 and 29,209,964 shares issued and outstanding at December 31, 2010 and June 30, 2011, respectively 3K
Additional paid-in capital 213.17M
Accumulated other comprehensive income 23K
Accumulated deficit -136.98M
Total Maxygen, Inc. stockholders' equity
Non-controlling interests
Total stockholders' equity 76.21M
Total liabilities and stockholders' equity 79.69M